[Preliminary study on cryopreservation of tissue engineered bone at -8 degrees C]

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Cryobiology

Background:

• Tissue-engineered bone aims to regenerate bone defects.
• Cryopreservation is crucial for storing engineered tissues.
• Optimizing cryopreservation is key to maintaining tissue bioactivity.

Purpose of the Study:

• To investigate the impact of different cryopreservation techniques on the bioactivity of tissue-engineered bone.
• To determine the optimal cryopreservation strategy for preserving mesenchymal stem cell (MSC) function within engineered bone constructs.

Main Methods:

• Mesenchymal stem cells (MSCs) were co-cultured with deproteinized bone to create tissue-engineered bone.
• Constructs were subjected to four conditions: preservation solution with cryomedium, preservation solution alone, no cryopreservation, and MSCs alone.
• Cryopreserved samples were stored at -80°C for three months. Assessed MSC adhesion, distribution, viability (MTT), alkaline phosphatase (ALP) activity, and cell cycle progression (flow cytometry).

Main Results:

• MSCs successfully adhered to and distributed within the engineered bone matrix.
• Cell viability and ALP activity were highest in the non-cryopreserved group (C), followed by the group with cryopreservation medium (A), and then the group without cryomedium (B).
• No significant changes in cell cycle distribution or abnormal cell formation were observed across groups.

Conclusions:

• The selection of an appropriate cryopreservative solution is critical for optimizing the bioactivity of tissue-engineered bone.
• Cryopreservation with a suitable medium can preserve key cellular functions, although non-cryopreserved tissue shows superior bioactivity.